A process for efficiently producing, through few steps, either a xanthine oxidase inhibitor, which is a therapeutic agent for hyperuricemia, or an intermediate therefor. The process is a novel coupling process which comprises subjecting a compound represented by formula (1) to coupling reaction with a compound represented by formula (2) in the presence of a transition metal compound to thereby obtain a compound represented by formula (3).